Get the Full Story, Without the Noise.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Heatwaves
Social Media
Artificial Intelligence
Taxes
Innovation
Stock Markets
Facebook
Infrastructure
Internet
Donald Trump
Radio
European Union
Parkinson's News Today image

News from Parkinson's News Today

Information about Parkinson's News Today

Where is Parkinson's News Today located?Parkinson's News Today's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Parkinson's News Today News

Brain Scan Breakthrough Reveals Why Parkinson’s Drugs Don’t Always Work
Health

Brain Scan Breakthrough Reveals Why Parkinson’s Drugs Don’t Always Work

67% Right coverage: 3 sources
Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work equally well for everyone. By mapping patients’ brain signals before and after taking the drug, they discovered that it sometimes activates the wrong brain regions, dampening its helpful effects. This breakthrough could pave the way for personalized treatment strategies, ensuring patients receive medications that target the …See the Story
Cognitive Decline Tied to Gut Microbes and Nutritional Access
Parkinson's Disease

Cognitive Decline Tied to Gut Microbes and Nutritional Access

100% Center coverage: 3 sources
A new study led in part by Mount Sinai researchers has found a compelling link between the composition of the gut microbiome and the risk of cognitive impairment (RCI) in adults, underscoring the complex role that both biology and social determinants-such as food insecurity-play in brain health.See the Story
Prediction of Mechanistic Subtypes of Parkinson’s Using Patient-Derived Stem Cell Models
Parkinson's Disease

Prediction of Mechanistic Subtypes of Parkinson’s Using Patient-Derived Stem Cell Models

100% Center coverage: 2 sources
Parkinson’s disease is a common, incurable neurodegenerative disorder that is clinically heterogeneous: it is likely that different cellular mechanisms drive the pathology in different individuals. So far it has not been possible to define the cellular mechanism underlying the neurodegenerative disease in life. We generated a machine learning-based model that can simultaneously predict the presence of disease and its primary mechanistic subtype …See the Story

Targeting Newly-Identified Brain Protein Brings Hope of New Treatment for Parkinson's Disease

100% Center coverage: 1 sources
Groundbreaking research by the University of Sydney has identified a new brain protein involved in the development of Parkinson's disease and a way to modify it, paving the way for future treatments for the disease.Parkinson's DiseaseSee the Story

Reimagining Parkinson’s Research: Unlocking the Power of Real-World Data and AI – RamaOnHealthcare

Parkinson’s Disease (PD) is considered one of the most complex and challenging neurodegenerative disorders of our time. It affects nearly one millionParkinson's DiseaseSee the Story

Parkinson’s may slow me down, but the journey is still enjoyable

Even though I can still drive, I always welcome the offer of a drive somewhere by somebody else. It’s not just about the convenience but the companionship that comes with it. Usually, it’s my husband, John, but often, it’s our good friends and neighbors who step in. Their patience and understanding make the journey easier and more enjoyable. I also like that they usually laugh at my jokes. I know I’m a slowpoke, which I blame on bradykinesia due…Parkinson's DiseaseRead Article

Levels of fat molecules found altered in Parkinson's patients' brains

People with Parkinson’s disease have altered levels of certain fat molecules, known as lipids, in their brains, and this may play a role in disease development and progression, a new study from the U.S. reports. The researchers used postmortem brain tissue samples to analyze changes in lipids in 40 Parkinson’s patients and 43 age- and sex-match individuals without the neurodegenerative disease. According to the team, “this is the first prospecti…Parkinson's Disease · Royal OakRead Article

Running slower, loving deeper: A reflection on aging with Parkinson’s

We all age, but some of us — human or not — seem to do it a little faster. Our dog, Jax, turned 10 this year. He’s a cockapoo mix with an easy smile and a heart big enough to stretch across our entire household. For most of his life, he was a ball of kinetic joy, bounding through the yard, chasing squirrels, and leaping into lakes without hesitation. He was tireless, loyal, fierce in play, and gentle in quiet moments. Lately, though, Jax has slo…Parkinson's Disease · United StatesRead Article

NLRP3 inhibitor found safe, well tolerated in Parkinson’s trial

VTX3232, an NLRP3 inhibitor being developed by Ventyx Biosciences as a treatment for Parkinson’s disease, was found to be safe and well tolerated after nearly one month of daily dosing in a clinical trial involving people with early-stage disease, according to the company. With these results, VTX3232 met the primary goal of the Phase 2a study (NCT06556173), which was conducted in Connecticut, Ventyx announced in a company press release. The open…Parkinson's Disease · MarylandRead Article

Can Ayurveda Control Parkinson’s Disease? Know From Patanjali’s Research

New Delhi: Parkinson’s is a disease that affects the brain and body movement. It causes shaking, memory loss, and trouble with balance. There is no permanent cure for it yet — only ways to control it. But now, Patanjali Research Institute has shared a new ray of hope through its latest research. According to the study, Patanjali’s Ayurvedic medicine Neurogrit Gold may help reduce memory loss caused by Parkinson’s. The research was done using a t…Parkinson's DiseaseSee the Story

Ventyx reports positive outcomes from trial of VTX3232 for Parkinson's

Ventyx Biosciences has reported encouraging top-line outcomes from its Phase IIa trial of VTX3232 for early-stage Parkinson's.The post Ventyx reports positive outcomes from trial of VTX3232 for Parkinson’s appeared first on Clinical Trials Arena.Parkinson's Disease · MarylandSee the Story

Breaking News Topics Related to Parkinson's News Today

Parkinson's Disease icon

Parkinson's Disease

Australia icon

Australia

Sports icon

Sports

Alzheimer's Disease icon

Alzheimer's Disease

Maryland icon

Maryland

Artificial Intelligence icon

Artificial Intelligence

United States icon

United States

News
For You
SearchBlindspotLocal